| P2093 | author name string | Burkhardt U | |
| | Höffler U | |
| | Müller HP | |
| | Holderrieth S | |
| P2860 | cites work | In vitro antimicrobial susceptibility of Actinobacillus actinomycetemcomitans | Q33730756 |
| | Oral ecology and person-to-person transmission of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis | Q33752030 |
| | The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. | Q33960800 |
| | Mechanisms of fluoroquinolone transport by human neutrophils. | Q33978050 |
| | The intra-oral translocation of periodontopathogens jeopardises the outcome of periodontal therapy. A review of the literature | Q34249696 |
| | Metronidazole: its use in clinical dentistry | Q34708837 |
| | Medium for use in antibiotic susceptibility testing of anaerobic bacteria | Q34983673 |
| | In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans | Q35862665 |
| | Relationship between conversion of localized juvenile periodontitis-susceptible children from health to disease and Actinobacillus actinomycetemcomitans leukotoxin promoter structure | Q36469729 |
| | In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations | Q36758145 |
| | Gingival fluid ciprofloxacin levels at healthy and inflamed human periodontal sites | Q36789986 |
| | Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to eight antimicrobial agents | Q38591661 |
| | Penetration of moxifloxacin into peripheral compartments in humans. | Q39471855 |
| | Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects | Q39558921 |
| | Penetration of ciprofloxacin into saliva and nasal secretions and effect of the drug on the oropharyngeal flora of ill subjects | Q39820029 |
| | Human pharmacokinetics and disposition of sarmoxicillin, a lipophilic amoxicillin prodrug | Q39855283 |
| | Susceptibility of Bacterium actinomycetem comitans to 45 antibiotics | Q40282209 |
| | Susceptibility of oral bacterial biofilms to antimicrobial agents | Q40994274 |
| | In vitro antimicrobial susceptibility of Porphyromonas gingivalis to azithromycin, a novel macrolide | Q41066102 |
| | Biofilm susceptibility to antimicrobials | Q41730624 |
| | Systemic antibiotic therapy in periodontics | Q41754764 |
| | The microbial challenge in periodontitis | Q41754941 |
| | Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study | Q43583699 |
| | Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans | Q44329575 |
| | Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis. I. Light, immunofluorescence and electron microscopic studies | Q44402604 |
| | Roxithromycin as a possible agent for prophylaxis of endocarditis: a study in normal volunteers | Q44482031 |
| | The effect of treatment on Actinobacillus actinomycetemcomitans in localized juvenile periodontitis | Q45167763 |
| | Microbial ecology of Actinobacillus actinomycetemcomitans, Eikenella corrodens and Capnocytophaga spp. in adult periodontitis. | Q51207768 |
| | Intraoral distribution of Actinobacillus actinomycetemcomitans in young adults with minimal periodontal disease. | Q52064741 |
| | Fluoroquinolones in the treatment of Actinobacillus actinomycetemcomitans-associated periodontitis. | Q53916018 |
| | Roxithromycin penetration into gingiva and alveolar bone of odontoiatric patients. | Q54102152 |
| | Clinical evaluation of roxithromycin in odontogenic orofacial infections. | Q54132292 |
| | Haemophili and related bacteria in the human oral cavity | Q58234792 |
| | Evaluation of the E test for antimicrobial susceptibility testing of Actinobacillus actinomycetemcomitans | Q67480907 |
| | E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms | Q67494928 |
| | Activity of metronidazole and its hydroxy metabolite against clinical isolates of Actinobacillus actinomycetemcomitans | Q68108348 |
| | Antibiotic susceptibility of anaerobic bacteria from the human oral cavity | Q69843304 |
| | Uptake of ciprofloxacin by human neutrophils | Q69974925 |
| | Distribution of Actinobacillus actinomycetemcomitans in localized juvenile periodontitis plaque: an electron immunocytochemical study | Q70017596 |
| | Tetracycline: levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part I. Concentrations in crevicular fluid after repeated doses | Q70190460 |
| | Metronidazole concentrations in human plasma, saliva, and gingival crevice fluid after a single dose | Q70312875 |
| | Treatment of localized juvenile periodontitis. Results after 5 years | Q70368824 |
| | Metronidazole in the treatment of localized juvenile periodontitis | Q70601447 |
| | Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline | Q70917423 |
| | Azithromycin in the treatment of periodontal disease. Effect on microbial flora | Q71851413 |
| | Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis | Q72007072 |
| | An evaluation of minocycline in patients with periodontal disease | Q72153273 |
| | Amoxycillin causes an enhanced uptake of metronidazole in Actinobacillus actinomycetemcomitans: a mechanism of synergy | Q72190861 |
| | Microbiological and clinical effects of metronidazole and amoxicillin in Actinobacillus actinomycetemcomitans-associated periodontitis. A 2-year evaluation | Q72332296 |
| | Kinetics of spiramycin/metronidazole (Rodogyl) in human gingival crevicular fluid, saliva and blood | Q72372696 |
| | A 2-year study of adjunctive minocycline-HCl in Actinobacillus actinomycetemcomitans-associated periodontitis | Q72843526 |
| | Failure of adjunctive minocycline-HCl to eliminate oral Actinobacillus actinomycetemcomitans | Q72887737 |
| | Penetration of clarithromycin into human saliva | Q72920998 |
| | Systemic doxycycline administration in the treatment of periodontal infections (I). Effect on the subgingival microbiota | Q73276847 |
| | Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva | Q73449136 |
| | Periodontal tissue disposition of azithromycin | Q74097764 |
| | Gingivitis in young adults with Actinobacillus actinomycetemcomitans | Q74298045 |
| | Eradication of Actinobacillus actinomycetemcomitans from the oral cavity in adult periodontitis | Q74386617 |
| | In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin | Q74512951 |
| | The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial | Q74744698 |
| | Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis | Q74744718 |
| | Clinical and microbiological effects of adjunctive antibiotics in treatment of localized juvenile periodontitis. A controlled clinical trial | Q77931117 |
| | Clinical and microbiological effects of initial periodontal therapy in conjunction with amoxicillin and clavulanic acid in patients with adult periodontitis. A randomised double-blind, placebo-controlled study | Q78019833 |
| | The Microbiology of Early-Onset Periodontitis: Association of Highly Toxic Actinobacillus actinomycetemcomitans Strains With Localized Juvenile Periodontitis | Q88056761 |
| | Antibiotic Susceptibilities of Periodontal Bacteria: In Vitro Susceptibilities to Eight Antimicrobial Agents | Q95810230 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibiotic | Q12187 |
| | Actinobacillus actinomycetemcomitans | Q62903868 |
| P304 | page(s) | 736-742 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | Journal of Clinical Periodontology | Q15638559 |
| P1476 | title | In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics | |
| P478 | volume | 29 | |